Axios @axios
Mark Cuban says Cost Plus Drugs — which uses a direct-to-consumer pharmacy model — is the only health tech investment that he has put his name on. "I put my name on it because what we’re really selling is not medication, it’s trust," he said at #AxiosBFD. https://t.co/3vmJVE8l8v — PolitiTweet.org
